|Day's Range||0.000 - 0.000|
|52 Week Range|
|PE Ratio (TTM)||-13.50|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Analyst notes were a big catalyst for pot stocks last week.
One clinical-stage drug developer soared 17%, while another with a huge cannabinoid-based pipeline plunged 23%.
A new federal budget brings near-term clarity to the cannabis industry.